|
|
|
- あいり ひがき
- 4 years ago
- Views:
Transcription
1
2 2016/17 P 1 P 8 P13 P18 P23 P28 7 P33 P41 15 P48 P65 GC-MS/MSLC-MS/MS
3 2016/ AH3 75.4% HI AH1pdm09 B AH3 D151GD151N HA AH1pdm09 AH3 B /17-1 -
4 well MDCKLLC-MK2HEp-2HeLa RD-18sVero Caco /17 1) 0.75% HI A(H1N1)pdm09 B 3 A(H3N2) 2 QIAamp Viral RNA Mini Kit QIAGEN RNA OneStep RT-PCR Kit QIAGEN NA RT-PCR PCR QIAQuick PCR Purification Kit QIAGEN DNA BigDye Terminator v3.1 Cycle Sequencing Kit Applied BiosystemsBigDye XTerminator KitApplied BiosystemsApplied Biosystems 3500 MEGA6 NJ AH1pdm09 NA H275Y 1) AH3 NA E119VD151VQ226HG248RK249ER292KN294S 1,3,4) B NA R150KD197ED197NI221TN294SG407S 1) 2016/ ) 6) - 2 -
5 / AH1pdm09 1.5%AH %B 7.7% B % B Victoria 15.4% A H1pdm09 1.5% B Yamagata 7.7% A H3 75.4% - 3 -
6 2016/ B Victria B Yamagata AH3 AH1pdm /17 AH3 2 AH1pdm B B 1:2 1:1.6 7)B AH3 D151GD151N NA HI AH3 49 A/Hong Kong/4801/2014 NA D151GD151N HI HA 3C.2a 10% 7) - 4 -
7 3C.2a 3C.2 3C.3a 3C.3 AH3 HA AH1pdm09 B 10 HI AH1pdm /18 WHO A/Michigan/45/2015 8) A/California/7/2009 AH3 2014/ /15 A/Hong Kong/4801/2014 A/Switzerland/ B - 5 -
8 A(H1N1)pdm09 NA A(H3N2) NA B NA /16-6 -
9 70% 1) :, 3, ),,,:,60,61-66,2009 3) Monto,A.S.,McKimm-Berschkin,et al.:antimicrobial Agents and Chemotherapy.,50, ,2006 4) Sheu,T.G.,Deyde,et al.:antimicrobial Agents and Chmotherapy.,52, , ) : l ) ; nsenshou01/houdou.html ),;2016/ ) WHO;Recommended composition of influenza virus vaccines for use in the northern hemisphere influenza season tion.pdf?ua=
10 9 28.6% 5~ g MPN MPN AD g No.2OXOID OXOIDOXOID - 8 -
11 9ml OXOID CCDA OXOID OXOID C.jejuniC.coli 10g C.jejuniC.coli McFarland 1 1ml 150g High Dose McFarland ml 150g (Low Dose) 25g g 100ml mL 9mL 3 100g MPN AD % % 7 C9 CD10 C1 C 2 C A B 6.9%5 /72-9 -
12 100.0% 80.0% 60.0% 40.0% 20.0% 0.0% 14.3% 28.6% 14.3% 14.3% 0.0% 0.0% 0.0%0.0% 0.0% 100.0% 80.0% 60.0% 40.0% 20.0% 0.0% 11.1% 0.0% 0.0% 0.0% 0.0% 33.3% 11.1% 0.0% A-1 A-2 B-1 B-2 C-1 C-2 D-1 D High dose Low Dose High Dose 56 Low Dose 28 MPN
13 ~7 6.9%5 / H %8 5 H %5 1 H %8/28 H %(17/168 ) H
14 - 12 -
15 - 13 -
16 Copy G
17 Copy G
18 - 16 -
19 - 17 -
20 LC/MS/MS (1) LC/MS 1mg/ml (2) 2 1 (3) (4) Waters Xevo TQD 1-1 LC Waters:HSS C181.8µm mm µL A B ml/min
21 Time(min) A B MS ESI+ 1.5kV 1200 L/hr MRM m/z CV(V) CE(eV) C (1) 1.0 g 100mL 5mL SepPak AC-2 400mg 3 C18(1g)tC18(900mg)HLB(500mg Waters C18 82% 2 60% 40% 1 15mL 5mL 15mL30mL45mL 2 C18 5mL BL C18 C18 HLB 82 BL mL 30mL 45mL
22 10 5mL 10mL 3 C18 15mL BL mL 10mL 5mL 10mL 40 (2) 4 13 C ppb ppb (3) ng/g 1000 ng/g
23 ng/g (ng/g) % % % ppb 2 ~ ~ 50 ng/g % 3 % % % 1000 % % LC/MS/MS
24
25 (1) GC 257 LC (2) %8.4(4.2) 10%(27.6) Trace0.83 % (3) -2 (4) 3 0.1mg/kg (5) GC 7890B MS 7000CAgilent LC ACQUITY UPLC-H Class MS Xevo TQD Waters
26 1-1 GC/MS/MS VF5MS 0.25mm 30m 0.25µm 70(2 ) 25/ 150 3/ 200 8/ 300(4 ) µl EI 70eV 1-2 LC/MS/MS Waters:HSS C18 1.8µm mm 45 A5mmol/L B5mmol/L 0.4 ml/min 2 µl A B L/hr550 ESI 0.75V (1) -2 A B 10 ml PSA ODSSep-Pak Vac 1g 2g Waters GC/NH2InertSep GC/NH2(500mg/500mg/6mL GL ) 2 GC/MS/MS LC/MS/MS GC/MS/MS PEG300 50ppm GC PEG ppm (2) GC
27 50200 RSD% GC LC % A % A A B
28 ODS 50 S/N 10 A B
29 - 27 -
30 (1) (2) (3) HLB200 mg 6 ccprime-hlb 200 mg 6 cc Waters (4) 5.0g 3 0.5ppm ppm (5) 100ppm 5ppm 2:8 (6) Waters Xevo TQD LC ACQUITY UPLC-H Class 1-1 LC Waters:BEH C18 1.7µm mm 50 A0.05 B 0.4 ml/min 10 µl Posi Time(min) A B MS ESI(+) 0.75 kv (+) 1200L/hr
31 33L/hr MRM (m/z) CVV CE(eV) RT(min) 1 Oxytetracycline Chlortetracycline Tetracycline Oxolinic_acid Ormetoprim Sulfaquinoxaline Sulfadimidine Sulfamonomethoxine Sulfamerazine Sulfamonomethoxine Trimethoprim Pyrimethamine Flubendazole RT 10mL 5.0 HLB PRiME HLB 0.2%(1:1:3) 50mL 10 ml 3,000rpm 10min 10 ml ml 30mL20mL ml 1.6 ml ml ( 5 5 ml (9:15 ml 10 ml Filter 0.2 µm LC/MS/MS
32 (1) (2) HLB HLB N PRiME-HLB HLB 70120RSD10 HLB PRiME-HLB N HLB PRiME -HLB (3) LC
33 2 HLB (ppm) (ppm) 0.5g 10mL RSD RSD Oxytetracycline Chlortetracycline Tetracycline Oxolinic_acid Ormetoprim Sulfaquinoxaline Sulfadimidine Sulfamonomethoxine Sulfamerazine Sulfadimethoxine Trimethoprim Pyrimethamine Flubendazole PRiME-HLB 0.5g 10mL g 5mL 10 (ppm) (ppm) RSD RSD Oxytetracycline Chlortetracycline Tetracycline Oxolinic_acid Ormetoprim Sulfaquinoxaline Sulfadimidine Sulfamonomethoxine Sulfamerazine Sulfadimethoxine
34 Trimethoprim Pyrimethamine Flubendazole HLB PRiME-HLB
35 - 33 -
36
37 100cm 2,12.5cm8cm100ml 50ml 200rpm 10min 0.2m ICS-1100 g/cm 2 / (g/cm 2 /day)
38 mg/m 2 NaCl E=1/2 mv 2 m: v:e
39 (m/s)2 (g/cm2/day) ^ /2 (mg/m 2 )NaCl
40 1/2 482m 181 9cm cm
41 () mg/m 2 NaCl mg/m 2 NaCl
42 mg/m 2 (m/s) 2 NaCl
43 m 4m 1.2km 1.2km 1.3km 1km m 15m 1.7km
44 US cm ) 1 1 ph EC SO4 2 NO3 Cl NH4 Na K Ca 2 Mg 2 ph EC ph EC 1 28 ph ph 5.6 EC 3.91mS/m 3.66mS/m phec ph EC [ms/m] H19 H20 H21 H22 H23 H24 H25 H26 H27 H H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 1 ph EC
45 Na Cl nss-so4 2 nssnon-sea salt NO3 [%] Na+ Cl- Mg2+ ss-so42- K+ nss-so42- ss-ca2+ NO3- nss-ca2+ NH4+ H28 5 H28 5 H+ 2 R1R2 28 R1 R2 3 R10 86% R1 R2 R1 [%] Cations + Anions [μeq/l] R2 [%] EC [ms/m] 3 R1 R2 EC EC Na K
46 NO3 nss-so4 2 NH4 9 3) 6 ph EC [mm] [ms/m] Na + K + [μmol/l] [μmol/l] NO 3 - nss-so 4 2- [μmol/l] [μmol/l] NH 4 + ph [μmol/l] ph unit H28 H28 H23H27 H23H27 H23H
![4 2 5 5 5 24 28 6 7 EC Na + [mm] 400 300 200 100 y = 0.8778x + 15.288 R² = 0.](/docs-images/98/137890006/images/47-0.jpg "84 [ms/m] 12 10 8 6 4 2 y = 1.0224x - 0.048 R² = 0.")
![9485 [μmol/l] 700 600 500 400 300 200 100 y = 1.0043x - 3.8525 R² = 0.](/docs-images/98/137890006/images/47-1.jpg "9517 0 0 100 200 300 400 0 0 2 4 6 8 10 12 0 0 100 200 300 400 500 600 700 [mm]")
47 EC Na + [mm] y = x R² = 0.84 [ms/m] y = x R² = [μmol/l] y = x R² = [mm] [ms/m] [μmol/l] 6 ECNa 1 1 EC Na 11km
48 EC Na Na Cl EC EC nss-so 4 2- NO 3 - NH y = x R² = y = x R² = y = x R² = [μmol/l] [μmol/l] 40 [μmol/l] [μmol/l] [μmol/l] [μmol/l] ph nss-ca y = 0.701x R² = [μmol/l] y = x R² = [μmol/l] 7 nss-so4 2 NO3 NH4 phnss-ca nss-so4 2 NO3 NH4 ph nss-ca 2 4m 15m ph
49 ph EC Na + Cl EC Na K NO3 nss-so4 2 NH4 9 2 nss-so4 2 NO3 NH4 ph nss-ca ) https:// 2) EANETTechnical Manual for Wet Deposition Monitoring in East Asia )
50 (1) ,24 (2) 1 St- 1 St- 2 St- 3 St- 4 St- 1 St- 2 St- 3 St-3 St-2 St-1 St-1 St-2 St-3 St
51 (3) 20 ph (4) 2 Shannon ASPT ASPT 10 ASPT ASPT ASPT ASPT ASPT =() 29 4 Shannon Shannon Weaver1963 () H n N ln n N S N nii 3 (1) 1 2 (a)(b) 3 4 Shannon -1 St- 1 30m 20cm
52 ASPT Shannon St- 2 30m 20cm 9 7 ASPT Shannon St- 3 40m 30cm ASPT ASPT Shannon St- 4 20m 40cm ASPT ASPT 26 Shannon
53 2 (a) (b)
54 3 4 4 ph 7 SS St DO St- 1St- 2St- 3 St ASPT St- 2 St- 1 St- 3St- 4 Shannon 26 St- 1 St- 2 St- 3St- 4 BOD
55 2 BOD75 ASPT BOD75% 10 ASPT St St- 1St- 3St BOD75%(mg/l) BOD75% ASPT H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 H ASPT BOD75%(mg/l) BOD75% ASPT H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 H ASPT (a) St- 1 (c)st- 3 BOD75%(mg/l) BOD75% ASPT H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 H ASPT BOD75%(mg/l) BOD75% ASPT H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 H ASPT (b) St- 2 (d)st- 4 2 BOD75% ASPT
56 (2) 5 6 (a)(b) 7 ASPT 8 Shannon 5-1 St- 1 3m 40 29cm/s 34m ASPT ASPT Shannon St- 2 6m 60 18cm/s ASPT 6.0 ASPT Shannon
57 6 (a) (b) -3 St- 3 8m 70cm ASPT ASPT Shannon
58 7 ASPT 8 8 ph St- 1 St- 3DO St- 1 St ASPT ASPT St- 2 7 ASPT ASPT St- 3 1 ASPT ASPT ASPT ASPT St
59 1 St- 3 Shannon St- 2 8 Shannon ASPT ASPT 3 St- 1 St- 3 BOD75 St- 1St BOD75 ASPT St St- 2St- 3 ASPT ASPT 4 (1) ASPT St- 2 St- 1 St- 3St- 4 Shannon 28 St- 1St- 3 St St BOD75%
60 ASPT St St- 1St- 3St BOD75%(mg/l) BOD75% ASPT ASPT H19 H20 H21 H22 H23 H24 H25 H26 H27 H ASPT (a)st- 1 1 (c)st- 3 2 BOD75%(mg/l) BOD75% ASPT ASPT H19 H20 H21 H22 H23 H24 H25 H26 H27 H ASPT BOD75%(mg/l) ASPT ASPT H19 H20 H21 H22 H23 H24 H25 H26 H27 H ASPT (b)st- 2 3 BOD75% ASPT (2) ASPT ASPT St- 1 St- 3 Shannon 3 St- 2 St- 1St BOD75 ASPT St St- 2St- 3 ASPT ASPT (3)
61
62 St
63 St- 2 St
64 St
65 (2) St
66 St- 2 St
67 12 COD 28 COD 2 COD COD COD COD COD COD No.2 No No.3 No1,3,4,6,7 No10,11,16 No1,2,3 ( 1) No11 No No7 B COD 3.0mg/L 8 A 2.0mg/L No.1 No.1 No.4 No.3 No.6 No.7 No.10 No
68 2.1 COD COD (75) 1 COD 1 COD75% (mg/l) No1,3,4,6,7 5 No6 No10 No1,2,3 28 No6 No ,8, No6,7,10 No m 3m 1m COD 4. 66
69 COD COD No No7 6 8 No10 No6 6 8 No No mg/L No6,7 6 6,7,10 3 2mg/L No.6No.7No.10 3 No6 No.6 No ,8,10 No.10 4, No No.6,7,10 No.2 No.6,7,10 No.2 No6 8,No ,8 No6No mg/L 2 No.6,7,10 8 No.2 6 No.6,7,10 No.2 67
70 COD (mg/l) COD mg/l 68
71 mg/l COD COD No.6,7,10 No.2 20,000 20,000 mg/l 15,000 10,000 5,000 15,000 10,000 5,
72 COD COD 12mg/l COD 2mg/l mg/l COD COD COD COD COD 6.2 COD COD COD COD COD 70
73 6.3 COD 4 10 COD 6.1 COD ,8 COD COD COD 6.4 COD COD 3 1 COD COD 1.5mg/l mg/l COD COD COD 7 2 COD COD COD COD COD 71
74 COD COD COD 1) 27 2) 72
75 COD mg/l mg/l 73
76 mg/l mg/l 74
77 a mg/l 75
78 GC-MS/MSLC-MS/MS GC 28
79 JR1520 JRBRT W TEL 025(231)1231 FAX 025(230)5818 eisei.rc@city.niigata.lg.jp
217/18 217 48 1. 2 AH1pdm9 AH3 B HI AH1pdm9 B AH3 D151GD151N HA 6 AH1pdm9 AH3 B 4 5 5 5 217/18-1 - 217 1 218 3 76 24 well MDCKLLC-MK2HEp-2HeLa RD-18sVero Caco-2 217/18 3 1).75% HI A(H1N1)pdm9 B 3 A(H3N2)
Microsoft Word - 14_LCMS_アクリルアミド
3--2-3-Iodo-2-propynyl butylcarbamate (IPBC) Carbamic acid, butyl-, 3-iodo-2-propynyl ester Iodocarb CAS 55406-53-6 C 8 H 12 NO 2 I C (g/cm 3 ) (mmhg) log P ow 281.09 (280.9910) 64 68 1.51 1.57 (20 C)
Ⅱ6.3界面活性剤
6.3 6.3.1 6.3.1 6.3.1.1 (1) (2) a) JIS K 0557 A3 b) JIS K 8891 c) (5g/L) d) (10g/L)JIS K 8576 1g 100mL e) (7+993)JIS K 8951 f) JIS K 8322 g) 0.1g 100mL 30mL 1L 500mL6.8mL 50g 1L h) 1L 500mL6.8mL 50g 1L
近畿中国四国農業研究センター研究報告 第７号
230 C B A D E 50m 558 0 1km (mg L 1 ) T N NO 2 3 N NH 4 N 2.0 0 (a) 2001 1.5 6 20 21 5 1.0 0.5 0.0 2.0 1.5 1.0 0.5 0.0 14:00 17:00 (b) 2001 7 3 4 20:00 23:00 2:00 (h) 5:00 8:00 11:00 10 0 5 10 15
LC LC ACQUITY UPLC H-Class ACQUITY UPLC CSH C mm 1.7 µm : THF/ 2/8 A 1 mm / 4/6 THF 2 mg/ml THF/ 2 THF 2 ACQUITY UPLC CSH C 18
ACQUITY UPLC H-Class/QDa Nihon Waters K.K., Tokyo, Japan TAG 1 3 1 1 8 9 TAG TAG TAG TAG TAG UV UV APCI ESI MS TAG Sn-2 Sn-3 Sn-1 C18: ACQUITY UPLC CSH C 18 ACQUITY UPLC H-Class 1. ACQUITY QDa TAG ACQUITY
外因性内分泌攪乱化学物質調査暫定マニュアル（水質、底質、水生生物）
N- 1) 2) 1) GC/MS HPLC GC/MS 2) 0.01~0.05µg/l 0.5~50µg/kg GC/MS SIM GC/MS SIM GC/MS SIM a) b) -d 10 -d 10 -d 12 -d 12 c) d) 600 C 4 e) 1 99.999% f) a) b) - IX-1 - c) (ODS) 200-1,000mg 5ml 5ml 5ml d) e)
<4D F736F F D B BA908593B98AC782AB82E593E082CC88C091538AC7979D82C98AD682B782E992868AD495F18D908F912E646F63>
12 62 1800 14 3 11 14 4 14 4 30 ... 1... 1... 1... 2... 5... 6... 7... 10... 13... 18... 19 21 22 24 27 28 31 32 33... 34... 35... 37 2 1,650mm () H=2,500W=2,000 460m 750m 500m 42.1m 1.15m () 100% 80%
☆H23 13－農薬一斉分析（大垣）.doc
13 56 2011 Examination of Determination of Residual Pesticides in Agricultural Products Yuki OHGAKI, Katsuhiro HAYASHI, Hiroyuki KAWAI, and Kyoko SHIMURA GC/MS 92 LC/MS/MS 60 150 n- 5 GC/MS 92 79 70% LC/MS/MS
ッ ー ー ー() () 2.5 () () 21 1) -1 2) -2 10 m 5 7 23 6 1)2) 3) -1-2 H23.4.25 -15-20 4 75 5 1) -1 (5) (3) (3) (2) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) 1) ( 23 6 8 ) 2) 22 3)
1 2 3 4 4 (1) 5 (2) 6 7 (1) 7 (2) 13 (3) 20 (4) 22 24 (1) 24 (2) 31 (3) 34 (4) 35 (5) 36 (6) 38 39 40 41 51 1 5 7 2 5 4 59 8 20 3 1 4 4 7 7 9 10 DNA GLP 10 4 11 12 15 7 SARS 17 11 4 19 4 22 4 5 2 1 24
LC/MS/MS によるフェノール類分析 日本ウォーターズ株式会社 2015 Waters Corporation 1 対象化合物 Cl HO HO HO フェノール 2- クロロフェノール (2-CPh) Cl 4-クロロフェノール (4-CPh) HO Cl HO Cl HO Cl Cl 2,4
LC/MS/MS による類分析 日本ウォーターズ株式会社 15 Waters Corporation 1 対象化合物 - クロロ (-CPh) 4-クロロ (4-CPh),4- ジクロロ (,4-DPh),6- ジクロロ (,6-DPh),4,6- トリクロロ (,4,6-TPh) 15 Waters Corporation 1 サンプル調製 ( 検量線 標準液 ) 5 標準溶液添加 (,,4,,,5uL)
平成26年度 化学物質分析法開発報告書
2,2-2,2 -Iminodiethanol Diethanol amine CAS 111-42-2 C 4 H 11 NO 2 105.1356-105.0790-28 C 1) 1.0881 g/cm 3 1)
第4次酸性雨全国調査報告書(平成16年度) -(Ⅱ)付表編-
1.12.24 P. 5.4.3.1 NO NOP. 5.4.3.2P. 5.4.3.3 P. 5.4.3.4 P. 2.18 2.19 P. 2.20 P. 2.21 P. P. 5.5.2.11 SOA P. 5.5.2.12 NO B A B 1.1 16 mm FRS Vol. 31 42006 1.2 ph 16 FRS ms/m FRS 1.3 16 Vol. 31 42006 μmol/l
untitled
2 1. 1.1 1 1.2 2 1.3 3 2. 2.1 4 2.2 5 2.3 2610 6 2.4 477 7 2.5 51917 8 2.6 9 2.7 10 2.8 11 3. 3.1 12 3.2 13 4. 4.1 14 5. 5.1 15 5.2 16 6. 6.1 17 1.1 1. 17 72900 39400 2 26.5km 7.9km 2.0km 1 1.2 1. 2 1.3
0.01mg/ ç 0.01 mg/ ç 0.01 mg/ ç 0.01 mg/ ç 0.05 mg/ ç 0.05 mg/ ç 0.01 mg/ ç 0.01 mg/ ç 0.0005mg/ ç 0.0005mg/ ç 0.02 mg/ ç 0.02 mg/ ç 0.002 mg/ ç 0.002 mg/ ç 0.004 mg/ ç 0.004 mg/ ç 0.02 mg/ ç 0.02 mg/
8 1. 2. 3. 4. 5. 6. 7. 8. 1... 1 1.1.... 1 1.1.1.... 1 1.1.2.... 6 1.2.... 8 1.2.1.... 8 1.2.2....11 1.2.3.... 12 1.2.4.... 12 1.2.5.... 12 1.2.6.... 13 1.2.7.... 14 1.3.... 15 1.3.1.... 15 1.3.2....
Microsoft Word - 14_LCMS_アクリルアミド
2,4- (2,4-Dichlorophenoxy) acetic acid 2,4-D 2,4-PA OH O O C A S 94-75-7 C 8 H 6 Cl 2 O 3 Cl Cl ( ) 221. (219.9694) 1) (g/cm 3 ) (25 C) 2) ( C) (.4 mm Hg) 2) ( C) 2) (mmhg) (2 C) 2) (mg/l) (25 C) log P
12-7 12-7 12-7 12-7 12-8 12-10 12-10 12-10 12-11 12-12 12-12 12-14 12-15 12-17 12-18 10 12-19 12-20 12-20 12-21 12-22 12-22 12-23 12-25 12-26 12-26 12-29 12-30 12-30 12-31 12-33 12-34 12-3 12-35 12-36
平成26年度 化学物質分析法開発報告書
2,2-2,2 -Iminodiethanol Diethanol amine CAS 111-42-2 C 4 H 11 NO 2 105.1356-105.0790-28 C 1) 1.0881 g/cm 3 1)
1 2 2 6 1 7 1. 9 2. 9 3. 9 2 13 1. 13 2. 14 3. 16 4. 16 5. 18 1 19 2 21 1. 21 2. 23 3. 23 4. 24 5. 24
13 12 1 2 2 6 1 7 1. 9 2. 9 3. 9 2 13 1. 13 2. 14 3. 16 4. 16 5. 18 1 19 2 21 1. 21 2. 23 3. 23 4. 24 5. 24 1 25 1. 25 2. 25 3. 27 (1) 27 (2) 49 (3) 53 2 55 1. 55 2. 55 56 1. 56 2. 56 3. 56 57 58 881m
2
2 3 4 1 1661 2 2.1 2.1.1 1610 1610 1 6 km 1248 2287 m 1663 1 5 11700 2.1.2 3 2 2 6 1844 2.1.3 10 7 4 44 3 3 2.1.4 41 BOD 54.8 mg/l 4 7 2.1.5 4 61 63 1 11 20 8 3. 3.1 NO 13 YES 65 5 5 YES 9 NO 24 YES 49
2D-UPLC/MS Catalin Doneanu, Keith Fadgen, StJohn Skilton, Martha Stapels, and Weibin Chen Waters Corporation, Milford, MA, U.S. 4 5 HCP UPLC/MS E HCP
2D-UPLC/MS Catalin Doneanu, Keith Fadgen, StJohn Skilton, Martha Stapels, and Weibin Chen Waters Corporation, Milford, MA, U.S. 4 5 HCP UPLC/MS E HCP DNA 1 100 ppm HCPHCP HCP HCP 2008 EMA HCP 1 2006 HCP
平成26年度 化学物質分析法開発報告書
N,N- N,N-Dimethylacetamide Acethyldimethylamine CAS 127-19-5 C 4 H 9 NO 87.12 ~ 87.14 87.68413 163-165 C 1) - 18.59 C 2) 1 mg/l 25 C 3) 3.3 hpa 2 C 4) log P ow -.77 2).9429 2/4 C 1) 3.1 4) 1.31E - 8 atm-m
14 8 1.1 1 1.2 3 1.2.1 3 1.2.2 3 1.3 5 1.4 8 1.5 9 1.6 10 1.7 11 1.7.1 11 1.7.2 11 1.7.3 11 1.7.4 12 1.7.5 12 2.1 13 2.2 13 2.3 13 2.4 14 2.5 14 3.1 15 3.1.1 15 3.1.2 16 3.2 22 3.2.1 22 3.2.2 22 4.1 23
1. Norovirus(NoV) NoV NoV NoV NoV NoV AM AM NoV 2. 1) S 2007 10 2007 11 12 1 2008 1 2 77 2) 77 1 AM AM n = 38 n = 39AM - 2.5mg/ml 37 2 RNA AM AM NoV genogroup(g) G PCR NoV 3) AM 1g NoV Mann-Whitney U 3.
[ OASIS SAMPLE-EXTRACTION PRODUCTS ] LC-MS HPLC UPLC 1
![[ OASIS SAMPLE-EXTRACTION PRODUCTS ] LC-MS HPLC UPLC 1](/thumbs/91/106630031.jpg "[ OASIS SAMPLE-EXTRACTION PRODUCTS ] LC-MS HPLC UPLC 1")
Simplify Sample Preparation [ SAMPLE PREPARATION SOLUTIONS ] [ OASIS SAMPLE-EXTRACTION PRODUCTS ] LC-MS HPLC UPLC 1 [ SAMPLE PREPARATION SOLUTIONS ] [ OASIS SAMPLE-EXTRACTION PRODUCTS ] 2 [ OASIS SAMPLE-EXTRACTION
京都盆地の地下水
28 1 29 8km 20km [1] [2-4] 1993 [5] [1] 1980 22(4) pp.8-22 [2] 1929 6 pp.568-588 [3] 1984 No.23 pp.1-100 [4] 1992 45(1) pp.54-62 [5] 1933 8(9) pp.417-430 20 km 8km 0.7 km 125 km 3 25 m 300 700 m 56 44
untitled
17131 2 80% BOD 1,790kg/ 70% BOD75 BOD BOD P P P P P H15 BOD 47mg/l 39 L L L L 75,000m 3 12,000m 3 27,000m 3 10m 3 H11 22 DO BODmg/L BODSS30 . 1410 Q. Q. Q. Q. N926
ab c d 6 12 1:25,000 28 3 2-1-3 18 2-1-10 25000 3120 10 14 15 16 7 2-1-4 1000ha 10100ha 110ha ha ha km 200ha 100m 0.3 ha 100m 1m 2-1-11 2-1-5 20cm 2-1-12 20cm 2003 1 05 12 2-1-13 1968 10 7 1968 7 1897
表 1. HPLC/MS/MS MRM パラメータ 表 2. GC/MS/MS MRM パラメータ 表 1 に HPLC/MS/MS 法による MRM パラメータを示します 1 化合物に対し 定量用のトランジション 確認用のトランジションとコーン電圧を設定しています 表 2 には GC/MS/MS
ACQUITY UPLC TM /MS/MS と GC/MS/MS によるベビーフード中の残留農薬の分析 No. 720007 20001436J 概要 EU の Baby Food Directive 2003/13/EC 1) では ベビーフード中の使用が禁止されている残留農薬について明示しています その濃度が 0.003mg/kg を超えているのか あるいは 0.004-0.008mg/kg
まえがき
JAAS0012006 1 -------------------------------------------------------------------------------------------------------- 1 2 --------------------------------------------------------------------------------------------------------
http://keirin.jp ...1 1....2 1.1...2 1.1.1...2 1.1.2...4 1.2...5 1.2.1...6 1.2.2...7 1.3...11 1.3.1...11 1.3.2...12 2....14 2.1...14 2.2...17 2.2.1 5...17 2.2.2...20 3....27 3.1...27 3.1.1...27 3.1.2...35
1 WSV SIR m/z Analyte RT (Min) SIR m/z Cone voltage (V) Ascorbic Acid (C).91 177 2 Thiamine (B1) 1.1 265 5 Nicotinic Acid (B3) 1.27 124 15 Pyridoxal (
ACQUITY UPLC H-Class ACQUITY QDa Mark E. Benvenuti, Dimple Shah, and Jennifer A. Burgess Waters Corporation, Milford, MA, USA MS ACQUITY QDa UPLC HPLC UV ACQUITY QDa LC EC 1925/26 CFR 21 HPLC 1 LC-MS ACQUITY
20 57
56 20 57 58 59 12 60 ph 61 62 CCA 63 64 ( 1) 700 7.5 86% 54 17 71 2) 700 6.8 86% 50 15 65 3) 600 700 5.7 84% 36 14 50 550 650 4.2 80% 21 6 27 40 500 3.6 78% 16 7 23 3.6 78% 16 7 23 400 700 4.0 78% 18 7
g g/cm3 g / cm3 g g g g/cm3 cm2 kv 1. 4cm 16 cm 4cm 20cm 18 cm L λ(x)=ax [kg/m] A x 4cm A 4cm 12 cm h h Y 0 a G 0.38h a b x r(x) x y = 1 h 0.38h G b h X x r(x) 1 S(x) = πr(x) 2 a,b, h,π
![1. 4cm 16 cm 4cm 20cm 18 cm L λ(x)=ax [kg/m] A x 4cm A 4cm 12 cm h h Y 0 a G 0.38h a b x r(x) x y = 1 h 0.38h G b h X x r(x) 1 S(x) = πr(x) 2 a,b, h,π](/thumbs/101/149329485.jpg "1. 4cm 16 cm 4cm 20cm 18 cm L λ(x)=ax [kg/m] A x 4cm A 4cm 12 cm h h Y 0 a G 0.38h a b x r(x) x y = 1 h 0.38h G b h X x r(x) 1 S(x) = πr(x) 2 a,b, h,π")
. 4cm 6 cm 4cm cm 8 cm λ()=a [kg/m] A 4cm A 4cm cm h h Y a G.38h a b () y = h.38h G b h X () S() = π() a,b, h,π V = ρ M = ρv G = M h S() 3 d a,b, h 4 G = 5 h a b a b = 6 ω() s v m θ() m v () θ() ω() dθ()
QIAquick Spin プロトコールとトラブルシューティング ( /2008)
March 2008 QIAquick Spin QIAquick PCR Purification Kit PCR 100 bp 10 kb QIAquick Nucleotide Removal Kit 17 40mer DNA 40 bp 10 kb QIAquick Gel Extraction Kit DNA 70 bp 10 kb Sample & Assay Technologies
Microsoft Word - 目次注意事項2.doc
I II 2009 1. 2. 12 50 3. 1. 2. 3 ( 0.1g, 0.01g, 0.001g ) 3. 4. 1. 2. ()A4 3. 000005 19 5 11 () 19 5 15 () EDTA " # $ 1000 500 =... mol/l Web 1) p.159 2) 1987pp.14-15 3) 1989pp.58-60 4) http://www.chem.zenkyo.h.kyoto-u.ac.jp/operation/
温泉の化学 １
H O 1,003 516 149 124 2,237 1974 90 110 1km 2,400 ( 100 Mg 200 (98 ) 43,665 mg 38,695 mg 19,000 mg 2000 2000 Na-Ca-Cl 806 1970 1989 10 1991 4 ph 1 981 10,000 1993... (^^; (SO_4^{2-}) " " 1973-1987 1970
Sigma-Aldrich (Poole,Dorset,UK) LGC Standards(Teddington,Surrey,UK) 1 mg/ml Sigma-Aldrich Greyhound Chromatography(Brikenhead,UK) / Waters ACQUITY UPL
ACQUITY UPLC I-Class/Xevo TQD Mark Roberts and Michelle Wood Waters Corporation, MS Technologies Centre, Manchester, UK ACQUITY UPLC I-Class/Xevo TQD 2 2 MRM 178 / 950 MS ACQUITY UPLC/ACQUITY TQD 2 1-3
) km 200 m ) ) ) ) ) ) ) kg kg ) 017 x y x 2 y 5x 5 y )
001 ) g 20 g 5 300 g 7 002 720 g 2 ) g 003 0.8 m 2 ) cm 2 004 12 15 1 3 1 ) 005 5 0.8 0.4 ) 6 006 5 2 3 66 ) 007 1 700 12 ) 008 0.315 ) 009 500 g ) kg 0.2 t 189 kg 17.1 kg 010 5 1 2 cm 3 cm )km 2-1 - 011
48 13 13 13 38 21 13 3 13 3.1 l l l l l l 4.1.1 5mm 0.5mm 5mm 10 500mL 500mL 500mL 20 1 200 / 4 5 6 3000G 20 G1118 R N 2 10-8 GG Rcm Nrpm 1μm 2 3000G 1 /1 4.1.2PCB PCB 5mm 0.5mm 5mm 10 500mL 500mL 500mL
<4D F736F F D C6E30385F A B B83932E444F43>
1,2,4-1,2,4-Trimethylbenzene Pseudocumene 1,3,5-1,3,5-Trimethylbenzene Mesitylene CH 3 CH 3 CH 3 CH 3 CH 3 CH 3 1,2,4-trimethylbenzene 1,3,5-trimethylbenzene CAS 95-63-6 CAS 108-67-8 C 9 H 12 C 9 H 12
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17-54 55 56 57 58 ( ) 54 7 55 56 57 58 10 54 55 57 58 56 25 27 25 27 20 22 25 22 1.4g 23 23 :1.8g
1 3 2 4 1983 2 1979 04 1 03 GDP 9.1% 1 GDP 1,000 04 3 10 04 01 12 WTO WTO 4 3 3 1979 1973 1974 1978 1978 11 1979 1982 1982 1984 1988 1989 1989 1998 SEPA 5 1979 1989 3 1,000 9 SEPA 10 1982 6 5 5 6 1993
3, ,104 t mg/l 30 mg/l BOD mg 14 C 8, /kg 11 8, 1 11 OH = cm 3 / sec 11 OH /cm ppm
3, 3-1 200019 4800 CAS 91941 1138 3, 3-4, 4 - -3, 3 - H 2 N Cl Cl NH 2 C 12 H 10 C l2 N 2 253.13 1 95 1. 2 3, 4 132-133 402 5 >200 5 700kg/m 3 5 8.73 = 1 5.610-8 kpa 4.210-7 mmhg20 4 6 log Pow3.51 3.57
地域再生計画
22 6,491ha 80 5,244ha 85.7 5,540ha 50km1 10,793 H17.5.1 15 35 51.7 1,943 1 50 9.5 351 12 2.4 130 2 16 13 5 14 1,545 1,019 35 1 20 10 3 15 3 3 H17.5.1 282 99 130 15 3 15 3 11 2 20 H16.12. 3 50km JR 9 4
H22応用物理化学演習1_濃度.ppt
1 2 4/12 4/19 4/27 5/10 5/17 5/24 5/31 (20 ) (20 ) (10 ) (50 ) 3 (mole fraction) X = (mol) (mol) i n 1, n 2,, n x N i X i = n i = n i n 1 + n 2 + + n x N 4 (molarity, M) 1 dm 3 ( L) (mol) (mol/l) = 1 L
食糧 その科学と技術 No.46( )
, IARC A ppb ppm, WHOµg/L GC GC GCMS GC MS, d O O O NH 2 Br 2 NEt 3 Br NH 2 NH 2 Br Br GC, [C H NO Br] + m/z [C H NO Br] m/z SIM [C H D NO Br] m/z [C H D NO Br] + m/z Br Br HBr [C H NO Br] + m/z GC -d
( ) ー ( () ) 250 200 150 100 50 0 51 20 54 59 33 35 91 92 93 98 99 94 6 7 7 8 9 11 18 17 18 20 22 23 10 9 8 9 9 9 62 40 66 74 41 47 21 22 23 24 25 26 10 8 6 4 2 0 m3/s 7 41.3 5 5 18.4
平成25年度 化学物質分析法開発報告書
2,4-2,4-Dimethylaniline 2,4-2,4-Xylidine CH 3 CH 3 CAS 95-68-1 C 8 H 11 N 121.18 121.0892-14.3 C 2) 214 C 2) 0.9723 g/cm 3 2) 0.133 mmhg (25 C) 1) 1390 mg/l (25 C) 1) 3.710 3 mg/l 25 C WSKOWWIN 5) 6.0710
25 ... 1... 1... 9... 9... 17... 21... 22... 22... 22... 22... 23... 25... 26... 27... 27... 27... 61... 61... 61... 64... 64... 64... 65... 65... 65... 66... 66... 67... 70 1.1.1 1.1.2 1.1.3 1.1.4 1.1.5
10月19日預かりＭＤ
19 10 18 13 00 17 00 461-8501 1-14-27 1 1. 2. 2 3. 2 6 1 15 41 3.1 3 600 2000 1,300 1997 2005 4 1970 70 70 80 80 80 1970 80 61 88 5 6 5 1980 4 30 2002 1 2002 1 500 2002 2002 5 5 2002 7 1961 88 1961 60
後期化学_01_濃度
2011 ( ) 1 4 1 100 g g % * 1 100 g 1 g 1 % * 2 (1 g)/(100 g) = 0.01 = 1 % 100 g 100 g 99 g 100 g 1 g 1 % 2.5 g 50 g (2.5 g)/(50 g) = 0.050 = 5.0 % 100 ml g 1 %(w/w) wt% % %(w/v) % / 2 % SI 2 / % 100 ml
橡14yoshi
8~9 GSI 5cm 35.8g16.7~58.2g 63.0g20.7~124.2g 61.4g20.4 ~102.2g 17 GSI 1.1 0~5.2 4.0 0~17.7 1.9 0~9.6 1.2 0~4.5 0.60~2.6 0.50~2.2 67 66 76 60 3 9.5~27.5 8.9g1.7~9.6 3.6g1.3~6.3 5.3g 2.0~9.2 4.6g 2.1~8.1
030801調査結果速報版.PDF
15 8 1 15 7 26 1. 2. 15 7 27 15 7 28 1 2 7:13 16:56 0:13 3km 45 346 108 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 3.9 3.10 3.11 3. 3.1 26 7 10 1 20cm 2 1 2 45 1/15 3 4 5,6 3 4 3 5 6 ( ) 7,8 8 7 8 2 55 9 10 9 10
1 1 1 11 25 2 28 2 2 6 10 8 30 4 26 1 38 5 1 2 25 57ha 25 3 24ha 3 4 83km2 15cm 5 8ha 30km2 8ha 30km2 4 14
3 9 11 25 1 2 2 3 3 6 7 1 2 4 2 1 1 1 11 25 2 28 2 2 6 10 8 30 4 26 1 38 5 1 2 25 57ha 25 3 24ha 3 4 83km2 15cm 5 8ha 30km2 8ha 30km2 4 14 60 m3 60 m3 4 1 11 26 30 2 3 15 50 2 1 4 7 110 2 4 21 180 1 38
% %
4 8 4 5 414.5 172.1 41.5% 39.8 10% 17 186.4 70.8 4 9 10 11 3 1-1 - 2-2 - - 3 - 10% - 4 - 4060% 5560% 60% 40% 3040 1520 1015 411 7 4 11 610 7080 5060 100 3040 13-5 - 1015 4045 3.04.0 5.06.0 1.52.0 1.01.5
JAJP.qxp
Agilent SPE SPE ...3...4...5...6...7...8 OPT...10 SCX...12 SAX...14 DVB...16 PS-DVB...17...18 C18EC...18 C18 ODS...19 C8...20 C2...21...21...22 (CN)...23...23...24 Si-SCX...25 Si-SAX...26...27 Florisil
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 5 2 5 24 () () () () () 1 1 150 50 50 1 1 ( 15,000 ) 150 ( 15,000 ) 100 50 50 1 1 ( 6,000 ) 150 ( 6,000 ) 100 50 50 1 1 150 1 1 150 100 0.25
gc-guide
...1...3 (Direct Injection)...5 OCI...7 PTV (...9 FID...11 ECD...13 AOC-20i/s...15...17...19 10 1 10 1 2µL 1µL 1mL 0.10.2mL He (He) 25cm/sec40cm/sec 30mL/min 1:501:100 Table Ex. Rtx-1, 515m :Ex. 100cm/sec
1937 West Nile HA 1957 A/H5 H7 A H1 15 N1 9 A(H1N1) A(H2N2) A(H3N2)
DNA RNA capsid 20 56 30 60 70 30 100 98 98 15 20 2w/v 0.05 0.5w/v 500 5,000ppm 76.9 81.4v/v 70v/v 2.5w/v 0.55w/v 0.3w/v ) ( ) 1937 West Nile 14 39 HA 1957 A/H5 H7 A H1 15 N1 9 A(H1N1) A(H2N2) A(H3N2) 2003
() in by NPO 26
埼 環 協 ニュース 通 巻 227 号 (2013 年 9 月 号 ) 一 般 社 団 法 人 埼 玉 県 環 境 計 量 協 議 会 General incorporated association Saitama-Prefecture Environmental Measurement Association 略 称 SEMA URL http://www.saikankyo.jp () in
2 2000 3 31 209 5.6.2 2000 3 31 209211 52
10 45m 700900mm 400600mm 1m 3060 12m 11.5cm 40cm 900mm 2000 5 71 2.4-1 2000 3 31 237245 2000 5 7172 51 2 2000 3 31 209 5.6.2 2000 3 31 209211 52 6 1 1 900mm 1 2 3 53 2000 3 31 234 5.6.34 2000 3 31 232234
/ /.. / PCA P 06講義ノート.dvi
2006 2006 6 26 [ ] 1 1.1 1. 2. 3. 2 4. 1 GDP GDP BOD. COD. DO. eg.1 GNP CO 2 eg.2 eg. 1 No... eg. 2 2 eg. 3... 1.2 S 8000 1 1000 2 3 1: ( 1999 6 11 2 ) 10 200 10 20 123 20 30 33 30 40 14 40 50 13 50 60
Taro10-01議事次第.PDF
15 3 27 ( ) 15:00 17:00 ( ) (1) (2) (3) 2-10 - - â â â â â â â â â â â â â â â â â â â â â â â â â â â â â â 3,100 330 490 1,700 7,200 10,300 9,000 500 650 660 270 7,400 6,700 720 1,200
67.5km 299.4km 2 2 2 16km 1/6 47km 2 1 1 (m) (km 2 ) 2,700 7.6 9,927 47.1 8,100 13.4 8,120 4.8 52 0.4 1,100 6.0 2,200 3.8 6,982 45.3 4,473 14.4 5,000 9.5 2 (km 2 ) (km) 1 299.4 67.5 2 284.5 38.8 3 267.0
レジャー産業と顧客満足の課題
1 1983 1983 2 3700 4800 5500 3300 15 3 100 1000 JR 4 14 2000 55% 72% 1878 2000 5 ( ) 22 1,040 5 946 42 15 25 30 30 4 14 39 1 24 8 6 390 33 800 34 34 3 35 () 37 40 1 50 40 46 47 2 55 4.43 4 16.98 40 55
Microsoft Word - 00”ŒŁ\”ƒf.doc
1-1 1 1-2 5S 3 1-3 5 2-1 1 2-2 3 2-3 5 2-4 7 3-1 1 3-2 3 3-3 5 3-4 7 4-1 1977 1 4-2 1987 7 4-3 17 4-4 26 1-1 1 1-2 5S 3 1-3 5 1-1 (1) (2) (3) 1. -1-1 1:15 1:10 2.. owf / 1.0 40 1.0 3.0 60 3.0 80 kg 0.25
<4D F736F F D F90858C6E5F C B B B838B>
Isobutyl alcohol IUPAC 2-methylpropan-1-ol 2--1-2-Methyl-1-Propanol, Isobutanol CH 3 H 3 C OH CAS 78-83-1 C 4 H 10 O log P ow ( C) ( C) (kpa) (g/l) 74.12 74.14 1) -108 2) 108 2) 1.2 2) 87 2) 0.8 2) (74.1214)
GDP GDP 1 98% 2
2016 2016 4 6 [ ] 1 1.1 1.1.1 1. 2. 3. 2 1 4. 1 700-800 1 GDP GDP 1 98% 2 1.1.2 BOD Biochemical Oxygen Demand BOD COD Chemical Oxygen Demand COD DO DO PM2.5 eg.1 GDP CO 2 eg.2 Life Cycle Assessment 3 eg.
2 2
1 1 143km 2,860km 2 1 2 2 3 3 4 4 5 6 1516 2,050mm 1,700mm 350mm 3,000mm 6 7 23km 7 8 8 9 9 10 10 11 0.53m 713cm 1.52.5m 20m 712cm 25mm 15cm 11 12 22cm 15cm 37.5cm 45cm 45cm 20cm 5276cm 2642cm 12 13 13
HPLC 1M KH 2 PO 4 ph ml Anthranilic acid: AnA 600 ml ml AnA 1.0 ml / min Anthranilic acid= PRESSURE 140 kgf / cm 2
15 10-1-3. 1. HPLC 1M KH 2 PO 4 ph 3.0 50 ml Anthranilic acid: AnA 600 ml 1-1. 350 ml AnA 1.0 ml / min Anthranilic acid=137.14 PRESSURE140 kgf / cm 2 TOSOH TSK-GEL ODS- 80 Ts 1) mg / ml AnA in (φ4.6 250
埼環協ニュース第229号
General incorporated association Saitama-Prefecture Environmental Measurement Association URL http://www.saikankyo.jp () ( 25 BOD 28 5 810 26 1 10 19.6 7 5.5 2.1 20 7 0 19 7 ( ) 20140131( ) (TSPSPMPM2.5)
low_ JAJP.qxd
LC/MS Chad Borges, Matthew Slawson, James Taccogno, and Dennis Crouch Center for uman Toxicology University of Utah Salt Lake City, UT USA John M. ughes Agilent Technologies, Inc. Pleasanton, CA USA (oa-tof)
LCMS14003:UHPLC-Orbitrap質量分析計による環境汚染物質のターゲット分析、ノンターゲット分析
UHPLC Orbitrap Application Note LCMS14003 Orbitrap CEC CEC 61 CEC 312 CEC SPE UHPLCThermo Scientifi c Orbitrap Thermo Scientifi c TraceFinder WWTP S1 PS 5 ºC S2 TWAS 5 ºC 1 WWTP 1 2 WWTP 2 1 2 S1 1 S2
untitled
Kw 1-12 1-13 Kw van t Hoff 0 0 0 H S d ln K H ln K = + = RT R d(1/ T ) R ln KW 1/T H 0 /R H 0 = 51.0 kj mol -1 HCl H + + Cl - H2O H + + OH - [] [H + ] [OH - ]=10-14 M 2 25 OH - x OH - [OH - ]=x [H + ]
AllPrep DNA/RNA Micro プロトコールとトラブルシューティング ( /2008)
July 2007 AllPrep DNA/RNA Micro DNA RNA 5 x 10 5 5 mg Sample & Assay Technologies DNA RNA 3 DNA RNA 11 DNA RNA 19 24 2 AllPrep DNA/RNA Micro 07/2007 DNA RNA RNA AllPrep DNA Spin Column DNA RNeasy MinElute
1 2 3 4 4.1 4.2 4.3 4.4 4.5 1
18 1 2 3 4 4.1 4.2 4.3 4.4 4.5 1 1 2 140 100 10 30 16 2 2 2 195070 GIS 17 6 9 6 16 6 29 7 20 1 8 31 9 2 9 21 10 19 12 14 2 9 1 100 2 1112 18 5 31 8 110 11 2931 12 13 4 12 25 2 23 5 () 3 19 2 200 3 3.1
1 1 2 2 3 3 4 5 5 6 6 7 7 8 8 9 9 10 10. 11 1 12 1 13 2 13 3 8 13 4 14 5 14 6 14 7 15 8 15 1 17 2 22 3 24 4 24 1 33 2 42 1 49 2 50 3 50 4 56 1 60 2 88 3 93 1 95 2 96 1 98 2 100 1 100 2 104 3 105 4 105
2 (FDA) 1 1 A D E K 1 LC UV 15 HPLC 3.5 UHPLC Agilent 12 Infinity LC Agilent 12 Infinity (G1311B) Agilent 12 Infinity (G13E) Agilent 12 Infinity (G131
1 Agilent 12 Infinity 1 Siji Joseph Agilent Technologies, Inc. Bangalore, India 12 1 2 4 5 3 2 1 4 1 12 14 4 2 Agilent 12 Infinity 2 4 5 3 2.5 1. 1.5 2. 2.5 3. 2 (RP-HPLC) Agilent Poroshell EC-C1 Agilent
untitled
5 400 350 300 23 23 23 25 250 200 150 19 166 212 211 233 227 100 50 78 98 96 103 121 0 1 2 3 4 5 (H2 H7) (H8 H12) (H13 H17) (H18 H22) (H23 H27) 565 938 981 918 859 6 1800 1600 1400 1200 1000 800 600 400
土壌の観察・実験テキスト −土壌を調べよう！−
( ) 2006 7 20 i 21 1962 1969 1987 1992 2005 65 1972 1977 1997 1977 1998 1982 1998 2002 2004 2005 SPP 1999 ii 1 g cm m 6378km ( ) 4.2, 4.3 5.1 7.1 8.1 4.1 7.3, 7.4 7.1 1 2 7.1 8.2 2 5 6 1, 2 2.3 4.2, 4.3
表紙／１５１７０８Ｈ
! " # $ % & ' ( ) ! #! $! " % & " ' " # * + $ %, &! & ', '! " # $ (! " # $ )! " # $ !!$ "! " # $ #! " # $ $! " # $ %! " # $ ! " # " 1 $ 2 " $ % 3 & % ' ( 4 ( ) * ' + 5, -. 6 / 0 0 +, 1 -. 2 3 /! /!%!!
() 1 1 2 2 3 2 3 308,000 308,000 308,000 199,200 253,000 308,000 77,100 115,200 211,000 308,000 211,200 62,200 185,000 308,000 154,000 308,000 2 () 308,000 308,000 253,000 308,000 77,100 211,000 308,000
外因性内分泌攪乱化学物質調査暫定マニュアル（水質、底質、水生生物）
p,p -DDT p,p -DDE p,p -DDD trans- cis- trans- cis- (PBB) (BaP) 25ng/L 5µg/kg GC/MS-SIM GC/MS-SIM GC/MS-SIM GC/MS-SIM (2-, 3-, 4- ) (4,4'- ) p,p'-ddt- 13 C 12 HCB- 13 C 6 BaP-d 12 -d10 -d 10 p- -d 14 1000
untitled
19 m 3 m 3 m 3 /s m 3 3 m 3 m 3 m 3 m 3 m 3 m 3 m 3 2km 2km 4km 3km 2km 2km 16km () 2km 2km 4km 4km 2km 2km 16km m 3 m 3 m 3 264,970 m 3 1,209.6 m 3 36,850 m 3 1,728 m 3 m 3 m 3 m 3 m 3 m 3 m 3 m
<4D F736F F D B6389EF8E9197BF95FA8ECB90FC92B28DB8>
23 1 23 7 11 (). 2. 3. 4. 22 22 5. 6. 52 59 6 22 1 3o. 2 1) 53.1ppm 1 盤.4ppm.1ppm 3 1 3 盤監 4 たたm. 監 たた m. 監.4.4.3.3.2.2 5.1.1. 4 監盤 7 8 9 1 11 12 1 2 3.1ppm 22 22. 13 14 1 監 1 盤 17 18 19 2 21 22 2) 54.4ppm.6ppm
64 3 g=9.85 m/s 2 g=9.791 m/s 2 36, km ( ) 1 () 2 () m/s : : a) b) kg/m kg/m k
63 3 Section 3.1 g 3.1 3.1: : 64 3 g=9.85 m/s 2 g=9.791 m/s 2 36, km ( ) 1 () 2 () 3 9.8 m/s 2 3.2 3.2: : a) b) 5 15 4 1 1. 1 3 14. 1 3 kg/m 3 2 3.3 1 3 5.8 1 3 kg/m 3 3 2.65 1 3 kg/m 3 4 6 m 3.1. 65 5
橡ミヤコグサ形質転換法・秋山
Page 1 2000 9 akiyama@biochem.osakafu-u.ac.jp VA 4 1999 9 2000 2 Plant J., 2, 487-496 (1992) Handberg K. and Stougaard J. Exp. Bot., 48,1357-1365 (1997) Stiller J. (Gresshoff PM) 4 80 5 10 20 ( ) < ecotype
CAS NC(CH 2 ) 4 CN 1,4- C 6 H 8 N c.c d = Pa
1 200117 21512 CAS 111693 110 NC(CH 2 ) 4 CN 1,4- C 6 H 8 N 2 108.14 1 99 2-1. 2 1 295 159 c.c. 550 3 1.7-4.9 20 d 0.965 4 3.73 = 1 0.3 Pa 0.002 mmhg20 2 log Pow-0.32 m/z 41, 1.0 68 0.54 54 0.43 4 Koc9-16
untitled
1 2 2.1 2.2 3 3.1 3.2 3.3 4 4.1 4.2 5 5.1 5.2 5.3 5.4 1 2 6 1 100 Szobolcs, I. (1989) 402.5 2005 102 2004-2006 (1) 1% (2) 0.1% (3) 0.01% km 3 / 14km 3 97%3% 0.8% 0.01% 19002000 9 70 % 5000 4000 1.15 0.352.5
98-02.PDF
1 982 2207 CAS 67630 2- H 3 C H 3 C CH OH C 3 H 8 O 60.10 1 99.9 % n- 1. 2-88.5 3 82.5 3 11.7c.c. 455 4 212 d 20 4 0.78505 3 2.1 = 1 4 4.4 kpa 33 mmhg20 4 log Pow0.05 0.07 5 m/z45, 1.0 43 0.19 27 0.17
untitled
206.2 0.5 25+85 25V 25+60. 50mø 65mø 00 m OR 000Hz 2. 000Mø 00V 3. 250V 4. 5. 6. 7. 8. 9. 7 27 37 5 25N 30N 36N 43N 2.6N 3N 3.3N 3.8N 70mø 85mø 0µs 70mø 85mø 00Mø 000 055Hz0.75mm 5/0 490m/s 2 ms 33 55
SEC (SEC) SEC SEC SEC 2
SEC (SEC) SEC SEC SEC 2 SEC ( 1) 1: SEC www.agilent.com/chem/jp 3 ( ) ( 2) ICH (Q6B) 3 lgg 8 7 6 5 4 1. 2. 3. 4. 5. Agilent AdvanceBio SEC 3 Å 7.8 x 3 mm 2.7 µm (p/n PL118-531) Agilent 126 Infinity LC
第2章 有機物汚濁指標の概要と問題点
3 COD Mn 3-1 3-1-1 OC 2 3 OC Oxygen Consumed 3-1 13 DO BOD OC 1 1970 OC KMnO 4 2 K 2 Cr 2 O 7 2 OC ph OC 50 OC JIS K0102 100 30 KMnO 4 3-1 COD 17 3-1 1973 1 KMnO 4 KMnO 4 COD Mn COD Mn COD COD Mn Cr COD